Biohaven initiates enrolment in migraine treatment trial,

Biohaven Pharmaceutical has enrolled the first subject in a Phase II/III clinical trial of oral zavegepant for the preventive treatment of migraine., Biohaven Pharmaceutical has enrolled the first subject in a Phase II/III clinical trial of oral zavegepant for the preventive treatment of migraine., Read More

Scroll to Top